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Dual polarization interferometryThe key molecular event underlying prion diseases is the conversion of the monomeric and α-helical cellular
form of the prion protein (PrPC) to the disease-associated state, which is aggregated and rich in β-sheet
(PrPSc). The molecular details associated with the conversion of PrPC into PrPSc are not fully understood. The
prion protein is attached to the cell membrane via a GPI lipid anchor and evidence suggests that the lipid
environment plays an important role in prion conversion and propagation. We have previously shown that
the interaction of the prion protein with anionic lipid membranes induces β-sheet structure and promotes
prion aggregation, whereas zwitterionic membranes stabilize the α-helical form of the protein. Here, we
report on the interaction of recombinant sheep prion protein with planar lipid membranes in real-time,
using dual polarization interferometry (DPI). Using this technique, the simultaneous evaluation of multiple
physical properties of PrP layers on membranes was achieved. The deposition of prion on membranes of
POPC and POPC/POPS mixtures was studied. The properties of the resulting protein layers were found to
depend on the lipid composition of the membranes. Denser and thicker protein deposits formed on lipid
membranes containing POPS compared to those formed on POPC. DPI thus provides a further insight on the
organization of PrP at the surface of lipid membranes.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Transmissible spongiform encephalopathies (TSEs), also known as
prion diseases, are associated with the conversion of the normal
cellular form of the prion protein (PrPC) to a pathogenic scrapie form
(PrPSc). Detailed biochemical analysis of PrPC and PrPSc revealedmajor
differences in the biochemical properties of both isoforms; PrPC is
monomeric and readily degradable by proteinase K, whereas PrPSc
forms highly insoluble aggregates and is resistant to protease K
digestion. The failure to identify any post-translational modiﬁcations
to the proteinmolecule [1] led to the suggestion that the differences in
the physical properties of both isoforms may be due to different
conformations. Structural analysis has shown that PrPC isolated from
healthy brains is predominantly α-helical, while PrPSc has a large
amount of β-sheet structure [2]. The precise molecular details of this
conformational transition are not clearly understood, although it is
apparent that the central event in the pathogenesis of prion diseases is
the refolding of PrPC to PrPSc.Fourier transform infrared; CD,
GPI, glycosyl phosphatidylino-
oyl-2-oleoyl-snglycero-3-phos-
-palm itoyl-2-oleoylsn-glycero-
lipid bilayers; TE, transverse
giform encephalopathy
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heiro).
ll rights reserved.PrPC is a N-glycosylated protein expressed at high levels in
neurons, where it is anchored to the plasma membrane via a glycosyl
phosphatidylinositol (GPI) lipid [3]. The conversion of the normal
cellular isoform of PrP to the aberrant disease-associated form occurs
after PrPC reaches the plasma membrane and evidence from scrapie-
infected neuronal cell lines suggests that the transformation of PrPC to
PrPSc occurs at the cell surface [4,5]. Other studies suggest that the
conversion process may also occur along the endocytic pathway [6] as
well as compartments of the secretory pathway [7,8]. However, it is
unclear whether a particular cellular site favors this conformational
transition.
Further evidence supporting lipid involvement in prion propa-
gation and disease pathogenesis comes from several cellular and in
vitro conversion studies. Alterations in the lipid environment of PrP
were shown to strongly inﬂuence the efﬁciency of prion propaga-
tion in neuroblastoma scrapie-infected cells [5,9]. Cell-free conver-
sion assays using a puriﬁed membrane fraction containing PrPC and
brain microsomes from scrapie-infected mice as a source of PrPSc
strongly support the view that lipids are involved in prion
replication [10,11]. The results from these studies have shown
that the conversion of PrPC to a protease-resistant conformation is
strongly inﬂuenced by the mode of association with lipid mem-
branes and that the insertion of PrPSc into lipid membranes is a
prerequisite for the conversion process. Also, in vitro conversion and
propagation of PrPC to infectious PrPSc using a modiﬁed version of
the protein misfolding cyclic ampliﬁcation (PMCA) assay reinforce
the signiﬁcance of lipid molecules in the formation of prions [12].
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duced infectious prions in vitro by using brain homogenates from
healthy mice as a source of PrPC and scrapie-infected mice as a
source of PrPSc. Although, this study greatly strengthens the prion
hypothesis, the complexity of the brain homogenates makes it
difﬁcult to establish the exact components of the infectious prion
unit. Deleault et al. [12] aimed at addressing this question by using
a puriﬁed preparation containing only native PrPC and co-puriﬁed
lipid molecules. The authors successfully showed the conversion
and propagation of the infectious prions. The signiﬁcance of the
lipid molecules in the production of PrPSc has yet to be determined,
although these later ﬁndings do corroborate our own view that the
conversion of PrP may be mediated via an interaction with lipid
molecules.
Our investigations have focused on in vitro studies of the
interaction of truncated PrP with lipid membranes, which allows an
in-depth understanding of the structural transitions PrP undergoes
during binding to membranes. In these studies, we reported that
the binding of PrP to model lipid membranes containing anionic
phospholipids (phosphatidyl glycerol) induces drastic changes in
the protein structure, resulting in the increase in β-sheet structure
and protein aggregation [14–16]. We showed that the extent and
nature of aggregates formed on lipid membranes depend on the
lipid composition of the membrane and initial conformational state
of the protein. Here, we examine in situ the interaction of the full-
length sheep prion protein, PrP(23–231), with supported lipid
bilayers (SLBs) of zwitterionic (POPC) and anionic (POPS) phos-
pholipids using dual polarization interferometry (DPI) [17,18]. DPI
has already been shown to be a useful technique for the
characterization of liposome adsorption and SLB formation on
solid surfaces [19]. This method enables the deposition of lipid and
protein to be monitored in real-time and their properties (thickness
and density) to be analyzed. The results provide new insight into
the formation of prion aggregates on lipid membranes.
2. Materials and methods
2.1. Expression, puriﬁcation, and refolding of PrP
Recombinant full-length sheep PrP (23–231), ARQ allele, was
expressed in Escherichia coli strain 1 B392. Expression was induced
for 4 h by adding 1 mM isopropyl β-D-thiogalactoside to a 1 L
culture of bacteria grown to OD600 of 0.6–0.8 in Terriﬁc Broth
supplemented with ampicillin (100 μg/mL). Recombinant protein
accumulated in inclusion bodies in the cytoplasm. Bacteria were
harvested by centrifugation at 4000 rpm for 30 min at 4 °C and
resuspended in cell lysis buffer; 50 mM Tris/1 mM EDTA/100 mM
NaCl, pH 8.0 containing 0.2 mg/mL lysozyme, 1 mg/mL deoxy-
cholic acid, and 10 μg/mL DNase. Cells were lysed by stirring at
4 °C for 3 h and centrifuged at 15,000 rpm for 15 min to isolate
the inclusion bodies containing rPrP. The inclusion bodies were
solubilized in buffer consisting of 8 M urea, 10 mM Tris–HCl,
100 mM sodium phosphate, and 10 mM β-mercaptoethanol, pH
8.0.
The soluble fraction, collected after centrifugation at 15,000 rpm
for 15 min, was applied to a Ni-NTA column (Qiagen). The column
had been equilibrated with 8 M urea, 10 mM Tris–HCl, 100 mM
sodium phosphate, and 10 mM β-mercaptoethanol, pH 8.0 at a ﬂow
rate of 3 mL/min. rPrP was eluted with 8 M urea, 10 mM Tris–HCl,
100 mM sodium phosphate and 10 mM β-mercaptoethanol, pH 4.5.
Fractions containing PrP as identiﬁed on SDS PAGE gels were pooled
and diluted 2-fold with 50 mM HEPES, pH 8.0 buffer containing 8 M
urea and 10 mM DTT and incubated overnight at 4 °C. PrP was
further puriﬁed by application to a cation exchange column (SP-
Sepharose; Amersham Biosciences) and eluted with a 50 mM HEPES
buffer, pH 8.0 containing 8 M urea and 1.5 M NaCl at a ﬂow rate of3 mL/min. Fractions containing rPrP were pooled and diluted to
0.1–0.5 mg/mL with 50 mM HEPES buffer containing 8 M urea and
oxidized using a 5 molar excess of Cu2+. The protein solution was
stirred overnight and refolded the following day by dialysis into 4
changes of 5 mM MES, pH 5.0 containing 10 mM EDTA to remove
the copper and a further two dialysis changes without the EDTA.
Protein was concentrated using an Amicon ultraﬁltration cell and
PrP concentration was determined spectrophotometrically using an
extinction coefﬁcient ɛ280 of 58,718 M–1 cm–1.
2.2. Infrared spectroscopy
Attenuated total reﬂection (ATR) Fourier transform infrared (FTIR)
spectra were acquired on a Bruker Vector 22 spectrometer equipped
with a liquid nitrogen cooled mercury cadmium telluride (MCT)
detector (Bruker, Coventry, UK). Spectra were recorded at room
temperature at a nominal resolution of 4 cm-1 in the range 1000–
4000 cm-1. The spectral contribution of atmospheric water was
minimized by the continuous purging of the sample chamber with
dried air (Jun-Air; Kent, UK). Residual water vapor peaks were
subtracted using reference spectra and baseline correction was
applied when necessary. The internal reﬂection element was a
germanium ATR plate (50×20×2 mm) with an aperture angle of
45°, yielding 25 internal reﬂections.
An aliquot of 50 μL of samples containing ∼30 μMPrP in 5mMMES
buffer, pH 5.0 was deposited on the ATR plate and a thin hydrated
protein ﬁlm was obtained by slowly evaporating the excess water
under a stream of N2 gas. All ATR FTIR spectra were collected after a
short period of H2O/D2O exchange in order to aid bond assignment
and the analysis of protein secondary structure [20]. Deposited pro-
tein ﬁlms were subjected to a stream of D2O-saturated nitrogen gas
for 10 minutes.
2.3. Circular dichroism
Far-UV (190–260 nm) CD spectra were measured on a JASCO J-
815 spectropolarimeter using 1-mm pathlength quartz cuvettes.
Typically, a scanning rate of 100 nm/min, a time constant of 1 s,
and a bandwidth of 1.0 nm were used. Spectra were measured at
20 ± 0.2 °C, with a resolution of 0.5 nm, and 8 scans were averaged
per spectrum. The buffer background was subtracted from the ﬁnal
spectra.
2.4. Lipid vesicles
Solutions of 20 mM POPC or POPC/POPS mixture (25% PS) were
prepared in chloroform and dried under nitrogen to form lipid
ﬁlms. The ﬁlms were further dried overnight under vacuum to
remove residual chloroform. The lipid ﬁlms were hydrated in
10 mM HEPES, pH 7.4 buffer and subjected to ﬁve cycles of
freezing–thawing using a dry ice–ethanol mixture and a 60 °C
water bath and extruded ten times through two 100 nm polycar-
bonate membranes at a pressure of 150 psi using a stainless steel
extrusion device (Lipex Biomembranes, Vancouver). The lipid
vesicles were diluted to 0.1 mg/mL with 10 mM HEPES containing
2 mM CaCl2 and 150 mM NaCl, pH 7.4.
2.5. Dual polarization interferometry
The Analight Bio 200 (Farﬁeld Sensors Ltd., Crewe, UK), a dual
polarization interferometer equipped with a 632.8 nm laser, was
used to characterize lipid and protein layers formed on unmodiﬁed
silicon oxynitride sensor chip. The design and functioning of this
device have been previously described [17,18]. Brieﬂy, the sensor
chip functions as an integrated Young's interferometer; it contains a
reference waveguide and a sensing waveguide. Linearly polarized
Fig. 1. Secondary structure of refolded recombinant sheep PrP (23–231). (A) Far-UV CD
spectra and (B) ATR FTIR spectra of full-length PrP, refolded under oxidizing conditions.
Full details of samples preparation are described in Materials and methods.
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exit. The resulting interference fringes are captured by the camera.
The laser light alternates between two orthogonal polarizations,
exciting the transverse electric (TE) and transverse magnetic (TM)
waveguide modes and yielding two independent measurements of
the interference fringes, one for each polarization. Adsorption of
material to the sensing waveguide changes the path length of the
propagated light through the sensing waveguide. This causes
changes in the positions of the interference fringes. The difference
in the position of the interference fringes between the reference
waveguide and the waveguide with the adsorbed material is termed
‘phase shift’ throughout the paper. It is related to the optical
properties of the adsorbed layer; the optical thickness, d and
refractive index, n. These are derived from the ﬁtting of the phase
shift data obtained at the two different polarizations with an
isotropic layer model. Two measurements of the phase shifts,
performed at the two different polarizations, uniquely determine
the values of layer refractive index and thickness for isotropic
layers. Density and mass of the adsorbed layers are then calculated
from d and n.
Determination of the optical properties of non-isotropic layers,
such as lipid bilayers, is more complex. The procedure was
investigated in detail previously [19] and amounts to assuming a
constant refractive index of 1.47 and using the degree of anisotropy
(birefringence) and layer thickness as ﬁtting parameters.
The Analite sensor chips contain two channels each with a
surface area of 15 mm2, allowing measurements with two separate
solutions to be performed simultaneously. Prior to loading the chip
in the instrument, the surface was prepared for the immobilization
of membranes by adding a few drops of 10% (v/v) Hellmanex II
for 10 min and then washing it with ethanol to remove any traces
of Hellmanex II. All experiments were performed at 20 °C and all
solutions were degassed prior to use. The clean sensor chip was
loaded into the instrument and calibrated with 80% ethanol/water
solution. HEPES (10 mM), pH 7.4 buffer was passed through both
channels at a ﬂow rate of 50 μL/min. This was followed by
injecting calibration solution (8:2 ethanol/HPLC grade water
mixture by weight) for 2 min before returning to HEPES buffer
followed by a 2-min water injection. The calibration procedure
provided the optical constants of the sensor chip prior to addition
of sample and the bulk refractive index of the running buffer to be
determined.
After the calibration procedure, the ﬂow rate was changed to
25 μL/min and 2×200 μL of 0.1 mg/mL POPC in 10 mM HEPES
buffer, pH 7.4 containing 2 mM CaCl2 and 150 mM NaCl was
injected onto the ﬁrst sample channel with buffer ﬂowing through
the second sample channel. This was followed by 4×200 μL
injection of 0.1 mg/mL POPC/POPS (molar ratio 3:1) onto the
second sample channel. Multiple lipid injection ensured maximal
levels of lipid immobilization onto the sensor chip. HEPES buffer
(10 mM), pH 7.4 was allowed to ﬂow over the sample channels for
∼10 min to ensure a stable bilayer. Recombinant PrP (23–231) was
diluted in 10 mM MES, pH 5.0 to provide PrP solutions in the
range of 0.05–2.5 μM. A volume of 100 μL with increasing
concentration of PrP was injected onto both sample channels at a
ﬂow rate of 25 μL/min.
Incubation of PrP on the bilayer surface was measured at 20 °C for
14–16 h. Following on from the last injection of the concentration-
dependent experiment described above, an injection at 2.5 μM PrP
(100 μL) was delivered to the sensor chip. The ﬂow was stopped after
75% of the sample had been injected to ensure that the PrP solution
covered the lipid surface. Changes in the protein-bound lipid layer
were monitored.
AnaLight Explorer software (Farﬁeld Scientiﬁc) was used for the
analysis of the raw data and determination of density, thickness, and
mass per unit area.3. Results
3.1. Structural characterization of refolded PrP
In this study, we have puriﬁed recombinant sheep PrP(23–231)
under oxidizing conditions from inclusion bodies generated in
Escherichia coli and refolded to a α-helical conformation, which
represents PrPC. The far-UV CD spectrum shows typical features of
a protein containing a large amount of α-helical structure with
well deﬁned minima at 208 and 222 nm (Fig. 1A). The FTIR
spectrum of refolded PrP exhibits a symmetrical amide I band
centered around 1648 cm–1, which is indicative of α-helix (Fig.
1B). Quantitative analysis of the amide I band revealed that
refolded sheep PrP has 54% α-helix, 25% random coil and 14% β-
sheet, in good agreement with solution NMR and crystal structures
of PrP [21,22].
Table 1
Layer properties of the immobilized lipid bilayers.
Lipid Tha (nm) Mass (ng)b
POPC 4.12±0.44 4.43±0.14
POPC/POPSc 3.81±0.60 4.07±0.20
Results are expressed as mean values±SEM of duplicate experiments and were
calculated as described before [19].
a Thickness of the lipid bilayer immobilized on the sensor surface.
b Mass deposited per unit area (mm2).
c POPC lipid membranes containing 25% POPS.
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Supported lipid bilayers (SLBs) were formed on DPI sensor chips
according to the procedure by Mashaghi et al. [19] (see also Materials
and methods). Formation of SLBs of POPC and POPC/POPS mixtures
was successfully achieved (Fig. 2) with DPI signals similar to those
reported before [19]. The DPI results are presented in two stages: as
raw signals and resolved data. Fig. 2A shows the raw data, which
consists of the phase shifts in TM and TE polarizations, recorded as a
function of time, as lipid vesicles containing POPC or mixtures of
POPC/POPS (25% PS) are allowed to adsorb onto the sensor chip.Fig. 2. Formation of supported lipid bilayers followed by DPI. (A) Phase changes for
transverse magnetic (TM) and transverse electric (TE) polarizations during the
deposition of stable bilayers on the DPI sensor chip. POPC vesicles were injected
twice onto channel 1, producing phase shifts in TM (solid line) and TE (long dashed
line). POPC/POPS vesicles were injected 4 times onto channel 2 and changes in TM
(dash–dot–dot) and TE (short dash) are shown. The start of each injection is indicated
by an arrow. Lipid vesicles were applied at a concentration of 0.1 mg/mL in 10 mM
HEPES, pH 7.4. (B) Resolution of the phase changes (TM and TE) into layer thickness for
lipid bilayers of POPC (solid line) and POPC/POPS (dashed line).Injection of the lipid vesicles results in changes in the TM and TE
phases. Two injections of POPC and four of POPC/POPS were required
to obtain a stable and constant signal. Typically, an increase of 12–14
radian for TM and 10–12 radian for TE was observed. The coverage of
the sensor chip was evaluated with BSA as reported before [23]. No
further changes of phase shifts were observed upon addition of BSA to
the sensor chip covered with POPC, indicating the formation of
continuous bilayers.
Lipid layer thickness was obtained from the phase shift data
following established procedures [19]. Fig. 2B shows the evolution of
thickness proﬁle obtained during the deposition of POPC and POPC/
POPS vesicles. An average value of bilayer thickness around 4 nm was
measured (Table 1), whichmatches the theoretical expected value for
a deposited lipid bilayer. A similar surface coverage of ∼4 ng/mm2
was measured for both lipid systems, which corresponds to a
deposition of around 60 ng of lipid on the senor chip.
3.3. Deposition of PrP on SLBs monitored by DPI
Typical phase shift data for the binding of PrP to SLBs of POPC and
mixed POPC/POPS are shown in Fig. 3A and B. For clarity, only the TM
phase data are shown; a similar phase proﬁle for TE was observed. The
detected phase changes are interpreted in terms of PrP adsorption to
the bilayers and consequent changes in the effective refractive index
and thickness of the layer at the sensor surface. Fig. 3A shows the TM
phase changes for an entire experiment, including formation of the
SLBs composed of POPC (solid line, 1) and POPC/POPS mixture
(dashed line, 2) and subsequent additions of increasing concentra-
tions of PrP (0.05–2.5 μM; 3) followed by overnight incubation (4). An
enhanced view showing the addition of increasing concentration of
PrP to SLBs (stage 3) is shown in Fig. 3B, where each PrP injection is
indicated by an arrow. The signiﬁcant net increase in TM and TE phase
shifts after returning to the running buffer indicates strong binding of
PrP to the SLBs with very little dissociation.
Analysis of the phase shift data from a DPI experiment provides
values for the mass of the deposited protein, the thickness and the
density of the protein layer. Fig. 4 presents the changes in the
properties of the protein layer for various protein concentrations. The
results show that PrP binds both to SLBs of POPC and POPC/POPS. A
signiﬁcantly greater amount of protein binds to POPC/POPS mem-
branes (3.2 ng/mm2) than to POPC bilayers (2.3 ng/mm2) and thicker
and more densely packed protein layers are formed on POPC/POPS
membranes compared to those on POPC (Table 2).
Interesting features in the changes in the density and thickness
proﬁles for the protein layers on both types of membranes are
noteworthy. Fig. 4B and C clearly shows that the majority of the
density increase occurs at the low protein concentrations (b0.25 μM),
whereas the bulk of the protein layer thickness increase occurs for
concentrations above 0.25 μM. In addition, for POPC membranes, the
density drops for protein concentrations above 0.25 μM.
Incubation of PrP revealed further changes in the protein layer
properties on membrane surfaces. An increase in both TM and TE was
observed for POPC/POPS membranes, suggesting further slow
Fig. 3. Deposition of PrP on SLBs monitored by DPI. Typical DPI results for the binding of
PrP to SLBs of POPC (solid line) and POPC/POPS mixtures, at molar ratio of 3:1 (dashed
line). (A) TM phase changes over the duration of a whole experiment, where different
stages are labeled with numbers: formation of SLBs of (1) POPC and (2) POPC/POPS; (3)
addition of increasing concentrations of PrP; (4) overnight incubation. (B) Enhanced
view of the incremental additions of PrP to SLBs (stage 3). Each step marked by arrows
represents the successive addition of protein: 0.05, 0.1, 0.25, 0.5, 1, and 2.5 μM.
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6 h (Fig. 3A, stage 4, for clarity only TM is shown). In contrast, no
appreciable change was observed with POPC membranes, indicating
that no further deposition of protein occurs. However, an increase in
density was detected (Table 2), and this suggests some structural
rearrangement of PrP on POPC membranes. Table 2 compares the
values for thickness, density, and mass of the protein layer on
membranes at the end points of the binding experiments (Fig. 4) with
those following overnight incubation. The data clearly show thatFig. 4. Layer properties of PrP on SLBs. Layer parameters extracted from DPI
measurements of incremental additions of PrP (0.1–2.5 μM) to POPC (square) and
POPC/POPS (circles). (A) mass of the protein deposited per unit area, (B) thickness of
the added protein layers, and (C) the density of the protein.
Table 2
Layer properties for PrP on lipid surfaces.
Lipid Tha (nm) Massb (ng) Density (g/cm3)
POPC Saturation 4.6±0.7 2.3±0.4 0.50±0.04
Incubation 4.4±0.1 2.5±0.5 0.59±0.05
POPC/POPSc Saturation 5.9±0.5 3.2±0.1 0.55±0.06
Incubation 7.7±1.2 4.4±0.1 0.58±0.01
Results are the mean±SEM of duplicate experiments. Values for thickness, mass, and
density of the protein layer on the two different lipid surfaces were taken at saturation
(the end point of the concentration-dependent experiment) and following overnight
incubation.
a Thickness of the protein layer deposited on the lipid bilayer. Values are taken at
surface saturation, see Fig. 4.
b Mass deposited per unit area (mm2).
c POPC lipid membranes containing 25% POPS.
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deposition of protein and a concomitant increase in thickness,
resulting in a protein layer of around 8 nm thick at the lipid surface.
4. Discussion
The membrane environment is believed to be essential in the
conversion of PrPC to PrPSc. However, most in vitro conversion studies
of PrP are carried out in solution. We have previously shown that
recombinant anchorless prion protein binds to small lipid vesicles in
aqueous solution and that the lipid environment has a profound effect
on the structural characteristics of the protein [15,16]. The extent and
nature of these structural changes depend on the pH and lipid
composition. Here, we have adsorbed lipid vesicles on solid supports
to create planar bilayers and used DPI to follow the deposition of PrP
on membranes. Details of the physical characteristics of PrP layers on
different membrane surfaces were obtained.
The DPI data show that PrP has a greater afﬁnity for membranes
containing POPS than for those of only POPC. PrP forms on average
thicker and denser protein layers on PS/PC membranes compared to
those formed on PC (Fig. 4). PrP deposited on PC membranes forms a
thinner protein layer with a thickness value of 4.6 ± 0.7 at saturation
(Fig. 4). The NMR structure of the folded C-terminal domain of sheep
PrP(121−231) gives the approximate dimensions of the protein at pH
4.5 of 4.6 nm (at the longest axis) × 4.1 nm [22]. Therefore, the
average thickness increase observed correlates well with the
formation of a homogeneous protein monolayer on the membrane
surface. In contrast, the DPI data with PS/PC membranes suggest the
formation of a heterogeneous protein layer with regions of multiple
layers of PrP at the membrane surface and this implies that the
presence of PS in the lipid bilayer leads to a greater propensity for PrP
to self-associate, resulting in large and dense protein domains.
We have in the past shown that electrostatic interactions between
positively charged residues on the protein surface and the negatively
charged lipid head groups are the driving force for the binding of PrP
to membranes. Full-length PrP at pH 7.4 is positively charged with a
net charge of +11. Binding of PrP to both POPC and POPC/POPS
membranes was accompanied by an increase in density (Fig. 4C). Full-
length recombinant PrP comprises a folded C-terminal domain and a
long unstructured N-terminal domain (residues 23–127) [22].
Therefore, it is plausible that the binding of PrP to PC and PC/PS
membranes leads to the ordering of N-terminus at the membrane
surface. Similar folding effects have also been suggested for the
binding of human PrP to lipid membranes [24].
Studies with β-amyloid peptide and α-synuclein have demon-
strated the potential of DPI to study the early stages of the aggregation
of these proteins (Farﬁeld application Note 004 and 021). This
prompted us to monitor possible changes in the properties of the
deposited PrP layers. Further deposition of PrP over a longer time
period was observed on POPC/POPS membranes. An increase in massand thickness and decrease in density (Table 2) suggest the formation
of diffuse layers of protein on the membrane surface. The incubation
of PrP with SLBs containing POPS exhibit typical characteristics of
protein aggregation, with the thickness of the protein layer increasing
while its density decreases.
The cellular event that initiates conversion of PrP at membranes
remains to be identiﬁed. It has been well established that the
asymmetric distribution of lipids across the cellular membrane is a
vital feature of healthy cells. The extracellular leaﬂet of the plasma
membranes is mostly composed of cholinephospholipids such as PC
and sphingomyelin, while PS is predominantly located in the
intracellular leaﬂet [25]. Redistribution of PS between the inner and
outer membrane leaﬂets would expose PrP to potentially dangerous
interactions with PS. Thus, perturbations of PS asymmetry in the
plasma membrane may play a role in prion conversion. Indeed,
previous ﬁndings show that the interaction of PrP with negatively
charged lipids induces β-sheet structure [15,16,24]. Conversion of
PrPC to PrPSc is accompanied by an increase in β-sheet structure.
Hence, it is reasonable to propose that PrP associated with anionic PS
lipids could serve as a substrate for the generation of PrPSc. In addition
to the possible role of lipids in the conversion of prions, the interaction
of PrP with membranes may also be involved in disease pathogenesis.
The mechanism of neuronal cell death in TSEs is undetermined.
Various hypotheses have been postulated to explain neuronal loss and
these include a direct perturbation of the plasma membrane of nerve
cells as a consequence of PrPSc accumulation.
In conclusion, we show the formation and growth of distinct PrP
layers on POPC and POPS membranes. The pattern of prion deposition
on membrane surfaces depends on the membrane composition.
Membranes containing POPS lipids lead to a greater tendency for PrP
to self-associate, resulting in a thick protein layer. Combined with
other previous ﬁndings [10,15,16], the current results strengthen the
hypothesis that PrP–lipid interactions are potentially important in
both the conversion and the pathogenesis of prion diseases.Acknowledgements
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